![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Taewoong Medical Co., Ltd. Gimpo-si Kr, based in South Korea, is a pharmaceutical company.
One of their significant offerings is Bovine pericardium, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2017-078 - Rev 00
This TSE Type CEP, issued on February 16, 2018, remains in force until March 16, 2023, ensuring its reliability within the pharmaceutical industry.